This educational activity is supported by an independent medical educational grant from Shionogi Inc. Post-exposure prophylaxis (PEP) is a treatment strategy that entails the prompt administration of ...

A large Japanese registry study identifies common symptom patterns and recovery timelines in patients with persistent post-COVID-19 vaccination symptoms, offering new insight into how these rare but ...

Fatigue is one of the most common and disabling symptoms of post-COVID-19 condition (PCC), often referred to as long COVID. Although the condition has been studied extensively since the pandemic, the ...

Due to the lack of specific Western medicine therapies for post-coronavirus disease 2019 (COVID-19) syndrome in clinical practice, this study aimed to investigate the efficacy of traditional Chinese ...

Ensitrelvir, an oral inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease, is approved in Japan for the treatment of mild-to-moderate coronavirus disease 2019 ...

The disease COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA load. But how much do we know about the disease and how can we cut through the thick layers of ...

Coronavirus has already caused myriad mental health problems for people around the world. These impacts, though, may persist even after restrictions are lifted. In this interview, Dr. Ali Jawaid ...